Story perspectives
FDA Issues AI Lifecycle Guidance Amid Helium Supply Crisis
4/23/2026
1 of 2
Tarver Addresses AI Safety
- Michelle Tarver, director of the FDA's Center for Devices and Radiological Health, announced final guidance on AI lifecycle management at neXus conference, addressing safety, transparency, and bias in AI-enabled devices.
- Tarver emphasized training AI algorithms on relevant data and robust postmarket monitoring to ensure patient safety.
- Moody’s Ratings warns that a helium supply crisis could disrupt AI infrastructure as Middle East disruptions threaten semiconductor production, risking AI growth.
1 / 2
